Despite the initial requirement of nitric oxide on Day 1 for systemic level pulmonary hypertension noted on TnECHO, repeat imaging prior use of angiotensin-II did not reveal concerns for long lasting heart dysfunction, pulmonary disease, or pulmonary hypertension. This evidence concerns the gene AGT and pulmonary hypertension.